Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV
Jovana Milić(University of Modena and Reggio Emilia), Giovanni Guaraldi(University of Modena and Reggio Emilia), Filippo Schepis(University of Modena and Reggio Emilia), Iacopo Franconi(University of Pisa), Giulia Besutti(University of Modena and Reggio Emilia), Federica Carli, Cristina Mussini(University of Modena and Reggio Emilia), Giada Sebastiani(McGill University Health Centre), Valentina Menozzi(University of Modena and Reggio Emilia), Alessandro Raimondi, Andrea Malagoli
Cited by 21
Related Papers
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|995
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Performance of Tests for Latent Tuberculosis in Different Groups of Immunocompromised Patients
|CHEST Journal|2009|157
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus
|Metabolism|2024|107
HHV-6A in Syncytial Giant-Cell Hepatitis
|New England Journal of Medicine|2008|102